Universidad Complutense de Madrid
E-Prints Complutense

Mast cell-mediated splanchnic cholestatic inflammation

Impacto

Downloads

Downloads per month over past year

Aller, María Ángeles and Martínez, Vicente and Arias, Ana and Nava, María Paz and Cuervas-Mons, Valentín and Vergara, Patri and Arias, Jaime (2019) Mast cell-mediated splanchnic cholestatic inflammation. Clinics and Research in Hepatology and Gastroenterology . pp. 1-14. ISSN 2210-741X (In Press)

[img] PDF
Restringido a Repository staff only hasta October 2020.
Creative Commons Attribution Non-commercial No Derivatives.

1MB

Official URL: https://www.sciencedirect.com/science/article/pii/S2210740119300385?via%3Dihub#!



Abstract

Introduction
Splanchnic mast cells increase in chronic liver and in acute-on-chronic liver diseases. We administered Ketotifen, a mast cell stabilizer, and measured the mast cells in the splanchnic organs of cholestatic rats.

Material and Methods
These groups were studied: sham-operated rats (S; n = 15), untreated microsurgical cholestasic rats (C; n = 20) and rats treated with Ketotifen: early (SK-e; n = 20 and CKe; n = 18), and late (SK-l; n = 15 and CK-l; n = 14).

Results
The cholestatic rats showed systemic and splanchnic impairments, such as ascites, portal hypertension, and biliary proliferation and fibrosis. The rats also showed a splanchnic increase of TNF-α, IL-1β and MCP-1, and a reduction of IL-4, IL-10 and antioxidants. An increase of VEGF in the ileum and mesenteric lymphatic complex was associated with a liver reduction of TGF-β1. Ketotifen reduces the degree of hepatic insufficiency and the splanchnic inflammatory mediators, as well as VEGF and TGF-ß1 levels. Ketotifen also reduces the connective tissue mast cells in the mesenteric lymphatic complex of cholestatic rats, while increases the hepatic mucosal mast cells.

Conclusions
In cholestatic rats, Ketotifen improves liver function and ascites, and also reduces pro-inflammatory mediators in the splanchnic area. The decrease in connective tissue mast cells in the mesenteric lymphatic complex due to the administration of Ketotifen would lead to the improvement of the inflammatory splanchnic response, and consequently the abovementioned complications.


Item Type:Article
Uncontrolled Keywords:Cholestasis, Mast cells, Portal hypertension, Ascites
Subjects:Medical sciences > Medicine > Gastroenterology and Hepatology
Medical sciences > Biology > Cytology
ID Code:57125
Deposited On:26 Sep 2019 14:57
Last Modified:01 Oct 2019 09:06

Origin of downloads

Repository Staff Only: item control page